Bank of America’s Aptevo Therapeutics APVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-7
| Closed | -$66 | – | 5755 |
|
|
2025
Q4 | $66 | Buy |
7
+5
| +250% | +$119 | ﹤0.01% | 6908 |
|
|
2025
Q3 | $39 | Buy |
+2
| New | +$80 | ﹤0.01% | 8065 |
|
|
2025
Q2 | – | Sell |
-6
| Closed | -$1.09K | – | 8299 |
|
|
2025
Q1 | $2.69K | Buy |
+6
| New | +$7.59K | ﹤0.01% | 7295 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 8046 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 8008 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 7838 |
|
|
2024
Q1 | – | Hold |
0
| – | -$1 | – | 7715 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7933 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7709 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7567 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7610 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7924 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7331 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 7987 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8234 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8191 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8084 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 7728 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6599 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5628 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6870 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6812 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6822 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 7055 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6735 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 7009 |
|
|
2018
Q3 | – | Hold |
0
| – | -$2K | – | 7246 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6903 |
|
|
2018
Q1 | – | Hold |
0
| – | -$1K | – | 7082 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6903 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 5991 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 5863 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 5918 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 5890 |
|
Other funds holding APVO
GCP
VCM
VFT
SS
DB
Bank of America's APVO Position: Q1 2026 in Review
Bank of America sold out of Aptevo Therapeutics (APVO) in Q1 2026, closing a stake of 7 shares — an estimated $66 sold.
Bank of America first reported a position in APVO in Q1 2025 and held it in 3 quarters. The position peaked at $2.69K in Q1 2025. 9 funds tracked by Wall St. Rank hold APVO as of Q1 2026.
- Bank of America reported no remaining Aptevo Therapeutics position as of Q1 2026 after selling out during the quarter.
- Bank of America sold 7 Aptevo Therapeutics shares in Q1 2026, an estimated $66.
- Bank of America first reported a position in Aptevo Therapeutics in Q1 2025 and held it in 3 quarters.
- Bank of America's Aptevo Therapeutics position peaked at $2.69K in Q1 2025.
- 9 funds tracked by Wall St. Rank held Aptevo Therapeutics as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.